Researchers Discover Therapeutic Potential of Non-Hallucinogenic Psychedelic

Researchers Discover Therapeutic Potential of Non-Hallucinogenic Psychedelic

Researchers have identified a psychedelic with no hallucinogenic characteristics using a new sensor.
Former NFL Player Kerry Rhodes Discusses Ayahuasca Experience With Tamron Hall

Former NFL Player Kerry Rhodes Discusses Ayahuasca Experience With Tamron Hall

Actor and former NFL safety Kerry Rhodes says the psychedelic compound ayahuasca has helped him recover from brain injuries.
Maine Bill Seeks to Legalize Therapeutic Use of Psilocybin

Maine Bill Seeks to Legalize Therapeutic Use of Psilocybin

Maine could soon become the second U.S. state to legalize the use of medicinal psilocybin for therapeutic use.

BIG Updates On MindMed, Compass, NUMI, TRYP, TRUFF, LOBE & More Plus Clinical Trial Progress

Hey psychedelic investors, this week we have Big Updates on MindMed, Compass, NUMI TRYP, TRUFF, ATAI, SHRM and LOBE Sciences and some amazing Ayahuasca study results which are detrimental to DMT research and this molecule potential effects on depression and anxiety. Timestamps: 0:00 - Intro 0:52- Effects of DMT, taken using the ayahuasca drink, on depression and anxiety 5:26 - MindMed ( MMED / MNMD / MMQ ) stared trading on NASDAQ 6:01 - MindMed finishes phase2a trials for Project LUCY 8:15 - Atai Life Sciences To IPO soon on the Nasdaq and plans to raise $100 million 9:17 - Compass Pathways ( CMPS) to raise $144 million dollars 10:35 - Numinus Wellness ( NUMI ) to begin phase 1 trial for naturally extracted psilocybin in their lab 12:15 TRYP Therapeutics (TRYP) to begin 2 phase 2a trials in 2021 13:50 - Champignon Brands (SHRM) to restart trading in Canada 14:31 - Lobe Sciences (LOBE) & Core one Labs ( CLABF) to create a Joint Venture 15:34 - Red Light Holland (TRUFF) has increased its points of sale by 144% and TRUFF and Halo Collective create Red Light Oregn, INC Link to Numinus (NUMI) press release: https://www.newswire.ca/news-releases/numinus-announces-phase-1-clinical-trial-of-natural-psilocybin-mushroom-extraction-prepared-at-company-lab-879795202.html?fbclid=IwAR1SmpbsTmXLs-mEy3vsUtAGKKk_xpf3FxJB3n2C-55zGJjiF0naXRetoUs Link to Compass Pathways (CMPS) : https://www.globenewswire.com/news-release/2021/04/27/2218191/0/en/COMPASS-Pathways-launches-proposed-public-offering.html https://ir.compasspathways.com/static-files/fe6cc477-a2ee-4b4a-bd46-8f8df0b62f30 Link To Atai life Sciences: https://www.atai.life/ Link To MindMed (MMED / MNMD / MMQ) https://mindmed.co/ Link to MindMed clinical trial: https://clinicaltrials.gov/ct2/show/NCT03153579?term=lsd+anxiety&draw=2&rank=1 Link to Red LIght Holland (TRUFF) : https://www.newsfilecorp.com/release/81879/Red-Light-Holland-and-Halo-Collective-Create-Red-Light-Oregon-Inc.-Forwarding-Intentions-to-Enter-Oregon-Medicinal-Psychedelic-Market https://www.cnbc.com/2021/04/21/atai-ipo-peter-thiel-backed-psychedelics-firm-to-raise-100-million.html Link to Champignon Brands (SHRM) : https://www.prnewswire.com/news-releases/champignon-brands-announces-revocation-of-cease-trade-orders-301275526.html Link to DMT study: https://www.sciencedirect.com/science/article/pii/S2666915321000251?fbclid=IwAR1-0HC9fxkL2Z47TEubMGsrqKInj61xLvBK4OW_C3FEQgv5VomoCSoNeQo Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #PsychedelicStocks #numiStock
Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study

Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study

A follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses with use of psilocybin treatment.
Psychedelic Business News Spotlight: April 30, 2021

Psychedelic Business News Spotlight: April 30, 2021

This week in psychedelic business news: Cybin’s experimental psychedelic takes aim at alcohol use disorder, Numinus seeks volunteers for its natural psilocybin extract, and another psychedelic company trades on Nasdaq.  Toronto-based…

My NEW Top 5 Psychedelic Stocks for 2021 || MindMed, NUMI, Atai and More

Here are our Top 5 Best Psychedelic Stock Picks for 2021. For those who have watched our top 5 shroom stocks for 2020, you might notice that some stocks have stayed and others have been replaced because they have proven to be worthy of The Psychedelic Investor’s list by filling in the top 3 factors that we look at before investing in the psychedelic medicines industry, such as: Clinical Trial Progress Molecules & Compounds Pipeline The Company’s war chest to sustain growth as a biotech company in a new industry But why invest in psychedelic stocks? Ever since last year, celebrity investors such as Kevin O’Leary and Peter Thiel decided to invest in the psychedelic/ shroom stocks industry, the industry grew from 2 or 3 companies to approximately 30 in 2021. This is probably one of the main reasons why we call this phenomenon the SHROOM BOOM! But why do such investors seem to believe so much in the potential explosive growth of psychedelic stocks? 1. Psychedelics have been shown in many recent clinical trials to help a variety of mental health issues, from addiction, to depression to PTSD and more. 2.These psychedelic companies are attempting to disrupt the 100 billion annual industry for mental health pharmaceuticals. 3.These psychedelic compounds have the potential to help millions world wide, this also presents an amazing opportunity for early investors. 4.Smart investors might realize that rather than going all in on one company in the field, it is probably best to diversify your risk and create a Psychedelic Medicines portfolio. So our top 5 Shroom Stock Pics for 2021 are: 5. Cybin ( CYBN on NEO & CLXPF on the OTC) 4. Numinus Wellness (LKYSF on the OTC & NUMI on the TSX) 3. Compass Pathways (CMPS on Nasdaq) 2. Atai Life Sciences - Soon to IPO on the Nasdaq 1 Mind Medicine or MindMed (MMED on NEO MNMD on Nasdaq & MMQ on FRA) Link to Cybin (CYBN) : https://www.cybin.com/ Link to Numinus (NUMI) : https://numinus.ca/ Link to Compass Pathways (CMPS) : https://ir.compasspathways.com/static-files/fe6cc477-a2ee-4b4a-bd46-8f8df0b62f30 Link To Atai life Sciences: https://www.atai.life/ Linke To MindMed (MMED / MNMD / MMQ) https://mindmed.co/ Timestamps: 0:00 - Intro 1:58 - Ranking criteria 3:42 - Cybin (CYBN) ( CLXPF) 6:24 - Numinus Wellness ( NUMI) 10:04 - Compass Pathways (CMPS) 13:52 - Atai Life Sciences 18:50 - MindMed ( MMED / MNMD/ MMQ ) Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor Clinical trials : DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #PsychedelicStocks #CMPSStock
First-of-Its-Kind 5-MeO-DMT Psychedelic Training Underscores New Research Potential

First-of-Its-Kind 5-MeO-DMT Psychedelic Training Underscores New Research Potential

Beckley Psytech and Fluence have partnered on a first of its kind training for 5-meo-DMT psychedelic treatment and therapy.
PharmaTher Files Patent on Ketamine for Diabetes and Obesity Treatment

PharmaTher Files Patent on Ketamine for Diabetes and Obesity Treatment

Ketamine may be a useful treatment for diabetes and obesity, according to a new patent filed by psychedelic company PharmTher.
Should Psychedelics Be Legal? Experts Weigh In

Should Psychedelics Be Legal? Experts Weigh In

,
Should psychedelics be legal? That was the topic of an expert-led debate featured on the Intelligence² Debates podcast.